Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$2,912,452
+$271,486 QoQ
Shares Held
22,665
+3.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,361
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monument Capital Management holds $17,122,223 across 11 Drug Manufacturers - General names. MRK ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,097 | $4,596,095 | |
| 2 | LLY |
ELI LILLY & Co
|
2,528 | $3,032,159 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
22,665 | $2,912,452 | |
| 4 | ABBV |
AbbVie Inc.
|
6,503 | $1,636,414 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,267 | $1,549,812 | |
| 6 | AMGN |
Amgen Inc
|
2,614 | $946,581 | |
| 7 | NVS |
Novartis AG
|
5,076 | $795,510 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,867 | $741,396 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,912,452 | 22,665 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,640,966 | 21,955 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,967,309 | 18,690 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $996,920 | 11,878 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $481,530 | 6,083 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $748,867 | 8,343 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $751,471 | 7,554 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $912,454 | 8,035 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,065,670 | 8,608 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,156,937 | 8,768 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $957,522 | 8,783 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,143,465 | 11,107 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,513,570 | 13,117 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,363,281 | 12,814 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $913,118 | 8,230 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $554,871 | 6,443 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $466,790 | 5,120 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $344,527 | 4,199 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $235,361 | 3,071 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $365,410 | 4,865 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $307,735 | 3,957 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $202,746 | 2,630 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,485,246 | 30,382 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,452,251 | 29,563 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,488,635 | 32,182 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,600,340 | 33,797 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||